Vascular Endothelium Growth Factor, Surgical Delay, and Skin Flap Survival
- 1 June 2004
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in Annals of Surgery
- Vol. 239 (6), 866-875
- https://doi.org/10.1097/01.sla.0000128682.53915.92
Abstract
Cytokines may be a mechanism by which surgical delay can increase flap survival. We previously found that preoperative vascular endothelium growth factor (VEGF) administration in the rat transverse rectus abdominis myocutaneous (TRAM) flap could improve skin paddle survival. In this study, we used partial elevation of the rat TRAM flap as a surgical delay to assess endogenous cytokine expression and tissue survival comparable to undelayed TRAM flaps. In Part I, TRAM flaps underwent surgical delay procedures; 7 days later, the flaps were completely elevated and reinset. At the same time, other flaps were raised and reinset without delay. Skin paddle survival in both groups was evaluated at 7 days. In Part II, skin biopsies from TRAM zones I to IV were taken at the time of delay and at intervals of 12, 24, 48, and 72 hours. Specimens were assessed for selected cytokine gene expression by reverse transcription-polymerase chain reaction analysis (TR-PCR). Surgical delay significantly (P < 0.001) increased skin paddle survival in the delayed TRAM flaps (16.14 +/- 1.53 cm, 81.9%) compared with undelayed flaps (7.68 +/- 3.16 cm, 40.9%). TGF-beta and PDGF expressions were not changed by surgical delay, but basic fibroblast growth factor (bFGF) and VEGF expressions increased significantly (P < 0.05 and P < 0.01) after delay. In the rat TRAM model, surgical delay resulted in increased VEGF expression and increased skin paddle survival. These results correlate with previous studies showing the preoperative injection of VEGF increases skin paddle survival. VEGF may be an important element in the delay phenomenon and may be an agent for pharmacological delay.Keywords
This publication has 51 references indexed in Scilit:
- Both Platelet-Derived Growth Factor Receptor (PDGFR)-α and PDGFR-β Promote Murine Fibroblast Cell MigrationBiochemical and Biophysical Research Communications, 2001
- THE EFFECT OF RECOMBINANT BASIC FIBROBLAST GROWTH FACTOR (bFGF) IN FIBRIN ADHESIVE VEHICLE ON THE HEALING OF ISCHAEMIC AND NORMAL INCISIONAL SKIN WOUNDSScandinavian Journal of Plastic and Reconstructive Surgery and Hand Surgery, 1998
- Effects of Vascular Endothelial Growth Factor on Hemodynamics and Cardiac PerformanceJournal of Cardiovascular Pharmacology, 1996
- The Surgically Delayed Unipedicled TRAM Flap for Breast ReconstructionAnnals of Plastic Surgery, 1996
- Hypoxic induction of vascular endothelial growth factor (VEGF) in human epithelial cells is mediated by increases in mRNA stabilityFEBS Letters, 1995
- Basic Fibroblast Growth Factor Has a Beneficial Effect on the Viability of Random Skin Flaps in RatsAnnals of Plastic Surgery, 1994
- Accelerated Maturation in Prefabricated Flaps by Transforming Growth Factor-βAnnals of Plastic Surgery, 1993
- Evolutionary grouping of the transforming growth factor-β superfamilyBiochemical and Biophysical Research Communications, 1992
- Recent developments in the cell biology of basic fibroblast growth factor.The Journal of cell biology, 1989
- Surgical delay and arachidonic acid metabolites: evidence for an inflammatory mechanism: an experimental study in ratsBritish Journal of Plastic Surgery, 1985